Autolus Therapeutics plc
AUTL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001730463
In the last 90 days, Autolus Therapeutics plc insiders filed 0 open-market purchases and 1 sale; 83 institutions reported holding it in 13F filings for Q2 2026, worth $212.0M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Autolus Therapeutics plc changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 96 | 2 | 89 | −5 |
| Shares | 144.7M | 3.52M | 139.3M | −1.89M (−1.3%) |
| Value | $235.7M | $5.74M | $277.1M | +$47.1M (+20.5%) |
2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (14)
Institutions that held Autolus Therapeutics plc at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 3,361,156 | $6.69M | 0.01% |
| Point72 Asset Management, L.P. | 305,359 | $607.7K | 0.00% |
| Arizona PSPRS Trust | 150,000 | $298.5K | 0.01% |
| Gsa Capital Partners LLP | 119,546 | $238.0K | 0.02% |
| Nano Cap New Millennium Growth Fund L P | 112,500 | $223.9K | 0.19% |
| OpenArc Corporate Advisory, LLC | 84,850 | $168.9K | 0.00% |
| Two Sigma Securities, LLC | 66,579 | $132.5K | 0.02% |
| Scientech Research LLC | 48,572 | $96.7K | 0.06% |
| Federation des caisses Desjardins du Quebec | 31,328 | $62.3K | 0.00% |
| SmartHarvest Portfolios, LLC | 21,365 | $42.5K | 0.01% |
| Independent Advisor Alliance | 13,885 | $27.6K | 0.00% |
| Icon Wealth Advisors, LLC | 10,000 | $19.9K | 0.00% |
| Garton & Associates Financial Advisors LLC | 600 | $1.19K | 0.00% |
| SageView Advisory Group, LLC | 75 | $150 | 0.00% |
Sold out (19)
Institutions that held Autolus Therapeutics plc at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Deep Track Capital, LP | 2,568,613 | $4.19M |
| Affinity Asset Advisors, LLC | 1,750,000 | $2.85M |
| Perpetual Ltd | 481,081 | $784.2K |
| Millennium Management LLC | 391,833 | $638.7K |
| HRT Financial LP | 210,172 | $342.0K |
| Two Sigma Investments, LP | 172,143 | $280.6K |
| Graham Capital Management, L.P. | 147,877 | $241.0K |
| Public Employees Retirement System of Ohio | 132,688 | $216.3K |
| Alps Advisors Inc | 124,606 | $203.1K |
| NEOS Investment Management LLC | 115,823 | $188.8K |
| Tema ETFs LLC | 115,823 | $188.8K |
| Aquatic Capital Management LLC | 104,684 | $170.6K |
| Squarepoint Ops LLC | 91,957 | $149.9K |
| Aigen Investment Management, LP | 65,617 | $107.0K |
| Virtus Investment Advisers, Inc. | 52,924 | $86.3K |
| Mariner, LLC | 10,322 | $16.8K |
| Group One Trading, L.P. | 8,381 | $13.7K |
| Barclays PLC | 7,883 | $12.8K |
| Principal Securities, Inc. | 37 | $60 |
Not filed for Q4 2025 yet (2)
Institutions that held Autolus Therapeutics plc at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| AXA Investment Managers S.A. | 3,361,156 | $5.48M |
| Cubist Systematic Strategies, LLC | 159,408 | $259.8K |